Sildenafil does not enhance but rather attenuates vasorelaxant effects of antidiabetic agents.

Q3 Medicine Journal of Smooth Muscle Research Pub Date : 2015-01-01 DOI:10.1540/jsmr.51.22
Jacob D Peuler, Laura E Phelps
{"title":"Sildenafil does not enhance but rather attenuates vasorelaxant effects of antidiabetic agents.","authors":"Jacob D Peuler,&nbsp;Laura E Phelps","doi":"10.1540/jsmr.51.22","DOIUrl":null,"url":null,"abstract":"<p><p>Type 2 diabetic men commonly experience erectile dysfunction for which phosphodiesterase-5 (PDE5) inhibitors like sildenafil (Viagra) are often recommended. By preventing degradation of cyclic guanosine monophosphate (cGMP) in vascular smooth muscle, these inhibitors also enhance arterial vasorelaxant effects of nitric oxide donors (which stimulate cGMP synthesis). In the present work, we confirmed this enhancing effect after co-administration of sildenafil with nitroprusside to freshly-isolated rat tail arterial tissues. However, in the same tissues we also observed that sildenafil does not enhance but rather attenuates vasorelaxant effects of three commonly-used antidiabetic drugs, i.e. the biguanide metformin and the thiazolidinediones pioglitazone and rosiglitazone. Indeed, sildenafil completely blocked vasorelaxant effects of low concentrations of these drugs. In addition, we found that this same novel anti-vasorelaxant interaction of sildenafil with these agents was abolished by either 1) omitting extracellular glucose or 2) inhibiting specific smooth muscle glycolytic pathways; pathways known to preferentially utilize extracellular glucose to fuel certain adenosine triphosphate (ATP)-dependent ion transporters: e.g. ATP-sensitive K channels, sarcoplasmic reticulum Ca-ATPase, plasma membrane Ca-ATPase and Na/K-ATPase. Accordingly, we suspect that altered activity of one or more of these ion transporters mediates the observed attenuating (anti-vasorelaxant) interaction of sildenafil with the antidiabetic drugs. The present results are relevant because hypertension is so common and difficult to control in Type 2 diabetes. The present data suggest that sildenafil might interfere with the known antihypertensive potential of metformin and the thiazolidinediones. However, they do not suggest that it will interact with them to cause life-threatening episodes of severe hypotension, as can occur when it is co-administered with nitrates. </p>","PeriodicalId":39619,"journal":{"name":"Journal of Smooth Muscle Research","volume":"51 ","pages":"22-36"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1540/jsmr.51.22","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Smooth Muscle Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1540/jsmr.51.22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 5

Abstract

Type 2 diabetic men commonly experience erectile dysfunction for which phosphodiesterase-5 (PDE5) inhibitors like sildenafil (Viagra) are often recommended. By preventing degradation of cyclic guanosine monophosphate (cGMP) in vascular smooth muscle, these inhibitors also enhance arterial vasorelaxant effects of nitric oxide donors (which stimulate cGMP synthesis). In the present work, we confirmed this enhancing effect after co-administration of sildenafil with nitroprusside to freshly-isolated rat tail arterial tissues. However, in the same tissues we also observed that sildenafil does not enhance but rather attenuates vasorelaxant effects of three commonly-used antidiabetic drugs, i.e. the biguanide metformin and the thiazolidinediones pioglitazone and rosiglitazone. Indeed, sildenafil completely blocked vasorelaxant effects of low concentrations of these drugs. In addition, we found that this same novel anti-vasorelaxant interaction of sildenafil with these agents was abolished by either 1) omitting extracellular glucose or 2) inhibiting specific smooth muscle glycolytic pathways; pathways known to preferentially utilize extracellular glucose to fuel certain adenosine triphosphate (ATP)-dependent ion transporters: e.g. ATP-sensitive K channels, sarcoplasmic reticulum Ca-ATPase, plasma membrane Ca-ATPase and Na/K-ATPase. Accordingly, we suspect that altered activity of one or more of these ion transporters mediates the observed attenuating (anti-vasorelaxant) interaction of sildenafil with the antidiabetic drugs. The present results are relevant because hypertension is so common and difficult to control in Type 2 diabetes. The present data suggest that sildenafil might interfere with the known antihypertensive potential of metformin and the thiazolidinediones. However, they do not suggest that it will interact with them to cause life-threatening episodes of severe hypotension, as can occur when it is co-administered with nitrates.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
西地那非不会增强而会减弱抗糖尿病药物的血管松弛作用。
2型糖尿病男性通常会出现勃起功能障碍,因此建议使用西地那非(伟哥)等磷酸二酯酶-5 (PDE5)抑制剂。通过阻止血管平滑肌中环鸟苷单磷酸(cGMP)的降解,这些抑制剂还增强了一氧化氮供体的动脉血管松弛作用(刺激cGMP的合成)。在本研究中,我们证实了西地那非与硝普塞联合应用于新鲜分离的大鼠尾动脉组织后的这种增强作用。然而,在相同的组织中,我们也观察到西地那非并没有增强,而是减弱了三种常用的降糖药的血管松弛作用,即双胍类二甲双胍和噻唑烷二酮类吡格列酮和罗格列酮。事实上,西地那非完全阻断了这些低浓度药物的血管松弛作用。此外,我们发现西地那非与这些药物的这种新的抗血管松弛相互作用被1)忽略细胞外葡萄糖或2)抑制特定的平滑肌糖酵解途径所消除;已知优先利用细胞外葡萄糖为某些三磷酸腺苷(ATP)依赖的离子转运体提供燃料的途径:例如ATP敏感的K通道,肌浆网ca -ATP酶,质膜ca -ATP酶和Na/K-ATP酶。因此,我们怀疑这些离子转运体中的一种或多种活性的改变介导了所观察到的西地那非与降糖药之间的减弱(抗血管松弛)相互作用。目前的结果是相关的,因为高血压是如此常见,难以控制的2型糖尿病。目前的数据表明,西地那非可能会干扰二甲双胍和噻唑烷二酮类药物已知的降压潜能。然而,他们并不认为它会与它们相互作用,导致危及生命的严重低血压发作,而当它与硝酸盐共同使用时可能会发生这种情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Smooth Muscle Research
Journal of Smooth Muscle Research Biochemistry, Genetics and Molecular Biology-Physiology
CiteScore
2.30
自引率
0.00%
发文量
7
审稿时长
10 weeks
期刊最新文献
The critical role of muscularis macrophages in modulating the enteric nervous system function and gastrointestinal motility Antispasmodic and antidiarrheal effects of Juniperus oxycedrus L. on the jejunum in rodents. Association of detrusor underactivity with aging and metabolic syndrome: suggestions from animal models. Antidiarrheal and antispasmodic effects of methanol fraction of Ammodaucus leucotrichus in gastrointestinal problems: an integrative medicine approach. Naloxone selectively inhibits vasoconstriction caused by phenylephrine but not endogenous noradrenaline in the rat mesenteric vasculature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1